ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618261 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618261; 2) Community: the network communities that were significantly associated with the response to NSC 618261; 3) Molecule: the relationships between components within communities and NSC 618261; 4) MDR: the compounds that were significantly associated with the NSC 618261.

NSC Compound Enrichment Correlation
NSC 756225 GW410563A 0.0385613993886 -0.25028678
NSC 762557 Null 0.0385613993886 -0.259003
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0385613993886001 0.40971158
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0385613993886001 0.35416545
NSC 129790 Null 0.0385613993886001 0.49926625
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0385613993886001 0.45453147
NSC 18805 .gamma.-Thujaplicine 0.0385613993886001 0.34286105
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0385613993886001 0.45451515
NSC 23925 Null 0.0385613993886001 0.27054567
NSC 244404 Null 0.0385613993886001 0.32028995
Total:153  Current:112    [First] [Prev] [Next] [Last]